Hsa-Mir-1 and Hsa-Mir-1229 expression levels in recurrent miscarriage patients before and after lymphocyte therapy in comparison to control groups

Hsa-Mir-1 and Hsa-Mir-1229 expression levels in recurrent miscarriage patients before and after lymphocyte therapy in comparison to control groups

Background. Recurrent pregnancy loss is defined as at least two consecutive clinical pregnancy losses before 20th week of gestation. In this study, we investigated microRNA-1 and microRNA-1229 in recurrent miscarriage patients before and after lymphocyte therapy in comparison to control group. Meth...

Full description

Bibliographic Details
Main Authors:	Mortaza Raeisi, Mehdi Yousefi, Javad Ahmadian Haris, Shahla Danaii, Mohammad Tofighifard, Pouya Bahlouli, leili Aghebati-Maleki
Format:	Article
Language:	fas
Published:	Tabriz University of Medical Sciences 2024-04-01
Series:	مجله پزشکی دانشگاه علوم پزشکی تبریز
Subjects:	lymphocyte therapy microrna inflammation recurrent pregnancy loss
Online Access:	https://mj.tbzmed.ac.ir/PDF/mj-46-19.pdf

Similar Items

Differential expression of hsa-miR-221, hsa-miR-21, hsa-miR-135b, and hsa-miR-29c suggests a field effect in oral cancer
by: Camile B. Lopes, et al.
Published: (2018-07-01)

Ebola virus infection, human Hsa-miR-1246, hsa-miR-320a and hsa-miR-196b-5p and predicted targets
by: Beuy Joob, et al.
Published: (2014-12-01)

Salivary microRNAs (hsa-miR-200a, hsa-miR-125a and hsa- miR-93) in relation to age, gender and histopathological parameters.
by: Shaimaa H Mudhir, et al.
Published: (2014-12-01)

The validity of salivary microRNAs (hsa-miR-200a, hsa-miR-125a and hsa- miR-93) as oral squamous cell carcinoma biomarker
by: Shaimaa H Mudhir, et al.
Published: (2014-09-01)

WASF3 overexpression affects the expression of circular RNA hsa-circ-0100153, which promotes breast cancer progression by sponging hsa-miR-31, hsa-miR-767-3p, and hsa-miR-935
by: Majid Mokhtari, et al.
Published: (2023-12-01)

Hsa-miR-21 and Hsa-miR-29 in Tissue as Potential Diagnostic and Prognostic Biomarkers for Gastric Cancer
by: Dahu Wang, et al.
Published: (2015-10-01)

"Seed-Milarity" confers to hsa-miR-210 and hsa-miR-147b similar functional activity.
by: Thomas Bertero, et al.
Published: (2012-01-01)

Hsa-Mir-320c, Hsa-Mir-200c-3p, and Hsa-Mir-449c-5p as Potential Specific miRNA Biomarkers of COPD: A Pilot Study
by: Noemi Cerón-Pisa, et al.
Published: (2022-03-01)

Expression Analysis of hsa-miR-181a-5p, hsa-miR-143-3p, hsa-miR-132-3p and hsa-miR-23a-3p as Biomarkers in Colorectal Cancer—Relationship to the Body Mass Index
by: Sofía Elena Tesolato, et al.
Published: (2023-06-01)

MicroRNAs hsa-miR-99b, hsa-miR-330, hsa-miR-126 and hsa-miR-30c: Potential Diagnostic Biomarkers in Natural Killer (NK) Cells of Patients with Chronic Fatigue Syndrome (CFS)/ Myalgic Encephalomyelitis (ME).
by: Robert D Petty, et al.
Published: (2016-01-01)

Diagnostic Significance of hsa-miR-21-5p, hsa-miR-192-5p, hsa-miR-155-5p, hsa-miR-199a-5p Panel and Ratios in Hepatocellular Carcinoma on Top of Liver Cirrhosis in HCV-Infected Patients
by: Mona A. Eldosoky, et al.
Published: (2023-02-01)

The Effect of Placenta Growth Factor Knockdown on hsa-miR-22-3p, hsa-let-7b-3p, hsa-miR-451b, and hsa-mir-4290 Expressions in MKN-45- derived Gastric Cancer Stem-like Cells
by: Zohreh Salehi, et al.
Published: (2018-04-01)

The importance of hsa-miR-28 in human malignancies
by: Seyede Fatemeh Hosseini, et al.
Published: (2023-05-01)

MicroRNAs hsa-mir-34a and hsa-mir-124 as biomarkers for predicting and monitoring the lithium treatment in bipolar disorder: in silico analysis
by: Orcun Avsar
Published: (2021-02-01)

Hsa-miR-19b-3p and Hsa-miR-23b-3P are the candidate biomarkers for bipolar disorder
by: Omran Davarinejad, et al.
Published: (2022-01-01)

Identification of hsa-miR-619-5p and hsa-miR-4454 in plasma-derived exosomes as a potential biomarker for lung adenocarcinoma
by: Linxiang Feng, et al.
Published: (2023-05-01)

hsa-miR-518-5p/hsa-miR-3135b Regulates the REL/SOD2 Pathway in Ischemic Cerebral Infarction
by: Boyan Zhao, et al.
Published: (2022-04-01)

Hypomethylation of the hsa-miR-191 Locus Causes High Expression of hsa-miR-191 and Promotes the Epithelial-to-Mesenchymal Transition in Hepatocellular Carcinoma
by: Yinghua He, et al.
Published: (2011-09-01)

The novel microRNAs hsa-miR-nov7 and hsa-miR-nov3 are over-expressed in locally advanced breast cancer.
by: Deepak Poduval, et al.
Published: (2020-01-01)

MicroRNA molecular profiling reveals increase expression of hsa-miR-186-5p, hsa-miR-320a-3p, and hsa-miR-486-5p with storage time in packed blood cells
by: AbdulFattah Fararjeh, et al.
Published: (2023-01-01)

Correction: The novel microRNAs hsa-miR-nov7 and hsa-miR-nov3 are over-expressed in locally advanced breast cancer.
by: Deepak Poduval, et al.
Published: (2021-01-01)

Correction: The novel microRNAs hsa-miR-nov7 and hsa-miR-nov3 are over-expressed in locally advanced breast cancer
by: Deepak Poduval, et al.
Published: (2021-01-01)

Qualitative and quantitative assessment of sperm miRNAs identifies hsa-miR-9-3p, hsa-miR-30b-5p and hsa-miR-122-5p as potential biomarkers of male infertility and sperm quality
by: Meghali Joshi, et al.
Published: (2022-08-01)

Cancer Cells’ Metabolism Dynamics in Renal Cell Carcinoma Patients’ Outcome: Influence of GLUT-1-Related hsa-miR-144 and hsa-miR-186
by: Mariana Morais, et al.
Published: (2021-04-01)

Expression profiles of hsa-miR-148a-3p and hsa-miR-125b-5p in human breast milk and infant formulae
by: Takeshi Chiba, et al.
Published: (2022-01-01)

Hsa_circ_0037897 may be a risk factor for essential hypertension via hsa-miR-145-5p
by: Zhenbo Tao, et al.
Published: (2021-04-01)

Hsa_circ_0046264 up-regulated BRCA2 to suppress lung cancer through targeting hsa-miR-1245
by: Liu Yang, et al.
Published: (2018-06-01)

Hsa_circ_0088233 Alleviates Proliferation, Migration, and Invasion of Prostate Cancer by Targeting hsa-miR-185-3p
by: Zhi-Hai Deng, et al.
Published: (2020-10-01)

Hsa-miR-665 Is a Promising Biomarker in Cancer Prognosis
by: Xuefeng Guan, et al.
Published: (2023-10-01)

Exploration of the Hsa-miR-1587–Protein Interaction and the Inhibition to CASK
by: Lulu Zhang, et al.
Published: (2021-10-01)

Obese Asthma Phenotype Is Associated with hsa-miR-26a-1-3p and hsa-miR-376a-3p Modulating the IGF Axis
by: Marta Gil-Martínez, et al.
Published: (2023-07-01)

Hsa_circ_0110757 upregulates ITGA1 to facilitate temozolomide resistance in glioma by suppressing hsa-miR-1298-5p
by: Haoyu Li, et al.
Published: (2021-03-01)

Hsa-miR-181a-5p, hsa-miR-182-5p, and hsa-miR-26a-5p as potential biomarkers for BCR-ABL1 among adult chronic myeloid leukemia treated with tyrosine kinase inhibitors at the molecular response
by: Aliza Mohd Yacob, et al.
Published: (2022-03-01)

microRNA hsa-miR-425-5p and hsa-miR-4523 expressions as biomarkers of active pulmonary tuberculosis, latent tuberculosis infection, and lymph node tuberculosis
by: Muhammad Nasrum Massi, et al.
Published: (2023-12-01)

Serum Extracellular Vesicle-Derived hsa-miR-2277-3p and hsa-miR-6813-3p Are Potential Biomarkers for Major Depression: A Preliminary Study
by: Issei Seki, et al.
Published: (2023-09-01)

Inhibition of herpes simplex virus type 1 replication by novel hsa-miR-7704 in vitro
by: Mehdi Shabani, et al.
Published: (2019-01-01)

Identification of hsa-miR-335 as a prognostic signature in gastric cancer.
by: Zhi Yan, et al.
Published: (2012-01-01)

Hsa-miR-335 regulates cardiac mesoderm and progenitor cell differentiation
by: Maryam Kay, et al.
Published: (2019-06-01)

Hsa-miR-557 Inhibits Osteosarcoma Growth Through Targeting KRAS
by: Zhi Qiao, et al.
Published: (2022-01-01)

rs4919510 in hsa-mir-608 is associated with outcome but not risk of colorectal cancer.
by: Bríd M Ryan, et al.
Published: (2012-01-01)